Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of GBP 294.14 million. The enterprise value is 282.68 million.

Market Cap	294.14M
Enterprise Value	282.68M

Important Dates

The next estimated earnings date is Wednesday, August 20, 2025.

Earnings Date	Aug 20, 2025
Ex-Dividend Date	May 9, 2025

Share Statistics

Current Share Class	18.26M
Shares Outstanding	n/a
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	-0.27%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	12.60M

Valuation Ratios

The trailing PE ratio is 32.54 and the forward PE ratio is 30.84.

PE Ratio	32.54
Forward PE	30.84
PS Ratio	6.62
PB Ratio	8.57
P/TBV Ratio	9.93
P/FCF Ratio	29.89
P/OCF Ratio	28.60
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.41, with an EV/FCF ratio of 28.73.

EV / Earnings	31.27
EV / Sales	6.42
EV / EBITDA	21.41
EV / EBIT	24.52
EV / FCF	28.73

Financial Position

The company has a current ratio of 3.91, with a Debt / Equity ratio of 0.06.

Current Ratio	3.91
Quick Ratio	2.52
Debt / Equity	0.06
Debt / EBITDA	0.14
Debt / FCF	0.20
Interest Coverage	194.08

Financial Efficiency

Return on equity (ROE) is 27.42% and return on invested capital (ROIC) is 21.22%.

Return on Equity (ROE)	27.42%
Return on Assets (ROA)	17.26%
Return on Invested Capital (ROIC)	21.22%
Return on Capital Employed (ROCE)	31.82%
Revenue Per Employee	288,527
Profits Per Employee	58,705
Employee Count	154
Asset Turnover	1.05
Inventory Turnover	0.73

Taxes

In the past 12 months, Medistim ASA has paid 2.75 million in taxes.

Income Tax	2.75M
Effective Tax Rate	23.34%

Stock Price Statistics

The stock price has increased by +30.84% in the last 52 weeks. The beta is 0.76, so Medistim ASA's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	+30.84%
50-Day Moving Average	186.75
200-Day Moving Average	193.10
Relative Strength Index (RSI)	61.23
Average Volume (20 Days)	464

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of GBP 44.43 million and earned 9.04 million in profits. Earnings per share was 0.49.

Revenue	44.43M
Gross Profit	35.66M
Operating Income	11.64M
Pretax Income	11.79M
Net Income	9.04M
EBITDA	12.68M
EBIT	11.64M
Earnings Per Share (EPS)	0.49

Full Income Statement

Balance Sheet

The company has 13.50 million in cash and 1.93 million in debt, giving a net cash position of 11.57 million.

Cash & Cash Equivalents	13.50M
Total Debt	1.93M
Net Cash	11.57M
Net Cash Per Share	n/a
Equity (Book Value)	34.32M
Book Value Per Share	1.88
Working Capital	25.75M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.29 million and capital expenditures -446,448, giving a free cash flow of 9.84 million.

Operating Cash Flow	10.29M
Capital Expenditures	-446,448
Free Cash Flow	9.84M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 80.25%, with operating and profit margins of 26.19% and 20.35%.

Gross Margin	80.25%
Operating Margin	26.19%
Pretax Margin	26.54%
Profit Margin	20.35%
EBITDA Margin	28.55%
EBIT Margin	26.19%
FCF Margin	22.15%

Dividends & Yields

This stock pays an annual dividend of 0.44, which amounts to a dividend yield of 0.19%.

Dividend Per Share	0.44
Dividend Yield	0.19%
Dividend Growth (YoY)	32.83%
Years of Dividend Growth	n/a
Payout Ratio	67.07%
Buyback Yield	-0.06%
Shareholder Yield	0.13%
Earnings Yield	3.07%
FCF Yield	3.35%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6